Skip to main content
SpringerLink
Log in

Management of Cutaneous Lupus Erythematosus

  • Chapter
Cutaneous Lupus Erythematosus

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Atra E, Sato EI (1993) Treatment of cutaneous lesions of systemic lupus erythematosus with thalidomide. Clin Exp Rheumatol 11:487–493

    PubMed  Google Scholar 

  • Bleumink GS, ter Borg EJ, Ramselaar CG, Ch Stricker BH (2001) Etanercept-induced subacute cutaneous lupus erythematosus. Rheuamtology (Oxford) 40:1317–1319

    Article  Google Scholar 

  • Boehm IB, Boehm GA, Bauer R (1998) Management of cutaneous lupus erythematosus with low-dose methotrexate: indication for modulation of inflammatory mechanisms. Rheumatol Int 18:59–62

    Google Scholar 

  • Bonsmann G, Schiller M, Luger TA, Stander S (2001) Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 44:925–931

    Article  PubMed  Google Scholar 

  • Callen JP, Kulp-Shorten CL, Hughes AP (2001) Subacute cutaneous lupus erythematosus associated with terbinafine therapy. Arch Dermatol 137:1196–1198

    PubMed  Google Scholar 

  • Callen JP, Spencer LV, Burruss JB, Holtman J (1991) Azathioprine: an effective, corticosteroids-sparing therapy for patients with recalcitrant cutaneous lupus erythematosus or with recalcitrant cutaneous leukocytoclastic vasculitis. Arch Dermatol 127:515–522

    Article  PubMed  Google Scholar 

  • Callen JP (2001) Therapy of cutaneous lupus erythematosus. Dermatologic Therapy 14:61–69

    Article  Google Scholar 

  • Crowson AN, Magro CM (1997) Subacute cutaneous lupus erythematosus arising in the setting of calcium channel blocker therapy. Hum Pathol 28:67–73

    Article  PubMed  Google Scholar 

  • Dalziel K, Going G, Cartwright PH, Marks R, Beveridge GW, Rowell NR (1986) Treatment of chronic discoid lupus erythematosus with an oral gold compound (Auranofin) Br J Dermatol 115:211–216

    PubMed  Google Scholar 

  • Delaporte E, Catteau B, Sabbagh N, Gosselin P, Breuillard F, Doutre MS, Broly F, Piette F, Bergoend H (1997) Traitment du lupus erythemateux chronique par la sulfasalazine: 11 observations. Ann Dermatol Venereol 124:151–156

    PubMed  Google Scholar 

  • Duong JD, Spigel T, Moxley RT III, Gaspari AA (1999) American experience with low-dose thalidomide therapy for severe cutaneous lupus erythematosus. Arch Dermatol 135:1079–1087

    Article  PubMed  Google Scholar 

  • Feldmann R, Salomon D, Saurat JH (1994) The association of the two antimalarials chloroquine and quinacrine for treatment-resistant chronic and subacute cutaneous lupus erythematosus. Dermatology 189:425–427

    PubMed  Google Scholar 

  • Gallego H, Crutchfield CE III, Lewis EJ, Gallego HJ (1999) Report of an association between discoid lupus erythematosus and smoking. Cutis 63:231–234

    PubMed  Google Scholar 

  • Genereau T, Chosidow O, Danel C, Cherin P, Herson S (1999) High-dose intravenous immunoglobulin in cutaneous lupus erythematosus. Arch Dermatol 135:1124–1125

    Article  PubMed  Google Scholar 

  • Goyal S, Nousari HC (2001) Treatment of resistant discoid lupus erythematosus of the palms and soles with mycophenolate mofetil. J Am Acad Dermatol 45:142–144

    Article  PubMed  Google Scholar 

  • Jewell ML, McCauliffe DP (2000) Patients with cutaneous lupus erythematosus who smoke are less responsive to antimalarial treatment. J Am Acad Dermatol 42:983–987

    Article  PubMed  Google Scholar 

  • Krivanek JFC, Paver WKA (1980) Further study of the use of clofazimine in discoid lupus erythematosus. Australasian J Dermatol 21:169–171

    Google Scholar 

  • Lagrange S, Piette JC, Becherel PA, Cacoub P, Frances C (1998) Sulfasalazine in the treatment of cutaneous lupus erythematosus: open trial in six cases. Lupus 7:21

    Google Scholar 

  • Lagrange S, Frances C, Roy S, Papo T, Piette JC (2004) High dose intravenous immune globulin in the treatment of refractory severe discoid lupus erythematosus. J Am Acad Dermatol, in press

    Google Scholar 

  • Lehmann P, Holzle E, Kind P, Goerz G, Plewig G (1990) Experimental reproduction of skin lesions in lupus erythematosus by UVA and UVB radiation. J Am Acad Dermatol 22:181–187

    PubMed  Google Scholar 

  • Millard TP, Hawk JLM, McGregor JM (2000) Photosensitivity in lupus. Lupus 9:3–10

    Article  PubMed  Google Scholar 

  • Neri R, Mosca M, Bernacchi E, Bombardieri S (1999) A case of SLE with acute, subacute and chronic cutaneous lesions successfully treated with dapsone. Lupus 8:240–243

    Article  PubMed  Google Scholar 

  • Newton RC, Jorizzo JL, Solomon AR, Sanchez R, Bell JD, Cavallo T (1986) Mechanism-oriented assessment of isotretinoin in chronic of Subacute cutaneous lupus erythematosus. Arch Dermatol 122:180–186

    Article  PubMed  Google Scholar 

  • Nicolas JF, Thivolet J, Kanitkis J, Lyonnet S (1990) Response of discoid and Subacute cutaneous lupus erythematosus to recombinant interferon alpha 2a. J Invest Dermatol 95:142S–145S

    Article  PubMed  Google Scholar 

  • Nyberg F, Hassan T, Puska P, Stephansson E, Hakkinen M, Ranki A, Ros AM (1997) Occurrence of polymorphous light eruption in lupus erythematosus. Br J Dermatol 136:217–221

    Article  PubMed  Google Scholar 

  • Ordi-Ros J, Cortes F, Cucurull E, Mauri M, Bujan S, Vilardell M (2000) Thalidomide in the treatment of cutaneous lupus erythematosus refractory to conventional therapy. J Rheumatol 27:1429–1433

    PubMed  Google Scholar 

  • Pashinian N, Wallace DJ, Klinenberg JR (1998) Mycophenolate mofetil for systemic lupus erythematosus. Arthritis Rheum 41:S110

    Article  Google Scholar 

  • Prinz JC, Meurer M, Reiter C, Rieber EP, Plewig G, Riethmuller G (1996) Treatment of severe cutaneous lupus erythematosus with a chimeric CD4 monoclonal antibody, cM-T412. J Am Acad Dermatol 34:244–252

    PubMed  Google Scholar 

  • Rahman P, Gladman DD, Urowitz MB (1998) Smoking interferes with efficacy of antimalarial therapy in cutaneous lupus. J Rheumatol 25:1716–1719

    PubMed  Google Scholar 

  • Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA (1985) Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 103:49–51

    PubMed  Google Scholar 

  • Rodriquez-Castellanos MA, Rubio JB, Gomez JFB, Mendoza AG (1995) Phenytoin in the treatment of discoid lupus erythematosus. Arch Dermatol 131:620–621

    Article  Google Scholar 

  • Rudnicka L, Szymanska E, Walecka I, Stowinska M (2000) Long-term cefuroxime axetil in subacute cutaneous lupus erythematosus. A report of three cases. Dermatology 200:129–131

    Article  PubMed  Google Scholar 

  • Ruzicka T, Meurer M, Brown-Falco O (1985) Treatment of cutaneous lupus erythematosus with etretinate. Acta Derm Venereol 65:324–329

    PubMed  Google Scholar 

  • Stege H, Budde MA, Grether S, Krutmann J (2000) Evaluation of the capacity of sunscreens to photoprotect lupus erythematosus patients by employing the photoprovocation test. Photodermatol Photoimmunol Photomed 16:256–259

    Article  PubMed  Google Scholar 

  • Tebbe B, Lauy M, Gollnick H (1992) Therapy of cutaneous lupus erythematosus with recombinant interferon alpha-2a. Eur J Dermatol 2:253–255

    Google Scholar 

Download references

Authors
  1. Jeffrey P. Callen
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hautklinik, Universitätsklinikum Düsseldorf, Moorenstraße 5, 40225, Düsseldorf, Germany

    Annegret Kuhn  & Thomas Ruzicka  & 

  2. HELIOS Klinikum Wuppertal Klinik für Dermatologie, Allergologie und Umweltmedizin, Universitätsklinikum Witten-Herdecke, Arrenbergerstraße 20, 42117, Wuppertal, Germany

    Percy Lehmann

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag Berlin · Heidelberg

About this chapter

Cite this chapter

Callen, J.P. (2005). Management of Cutaneous Lupus Erythematosus. In: Kuhn, A., Lehmann, P., Ruzicka, T. (eds) Cutaneous Lupus Erythematosus. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-26581-3_31

Download citation

  • DOI: https://doi.org/10.1007/3-540-26581-3_31

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-44266-0

  • Online ISBN: 978-3-540-26581-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation